Status:
UNKNOWN
Validation and Reliability of Iris Cameras in Mucopolysaccharidoses
Lead Sponsor:
Manchester University NHS Foundation Trust
Collaborating Sponsors:
Orchard Therapeutics
Conditions:
Mucopolysaccharidoses
Eligibility:
All Genders
Brief Summary
To assess the reliablity and validity of 2 new iris cameras in the assement of corneal opacification in mucopolysaccharidoses
Detailed Description
The mucopolysaccharidoses (MPS) are a group of disorders resulting from accumulation of glycosaminoglycans within various tissues including the eye. This can result in visual loss from corneal opacifi...
Eligibility Criteria
Inclusion
- Any patient aged 0-100 with MPS type I, type III, type IV and type VI. Type VII MPS patients may also be eligible.
- For the control group -
- Participants of any age currently being followed at MREH that have an eye condition unrelated to the cornea as established by clinical examination.
Exclusion
- MPS II
Key Trial Info
Start Date :
March 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 8 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05354219
Start Date
March 8 2023
End Date
September 8 2023
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, United Kingdom, M13 9WL